Program
10:00 h. – Institutional welcome
- R. Hon. Mr. Pere Aragonès i Garcia, President of the Government of Catalonia
10:10 h. – Presentation of the main results from the 2022 BioRegion Report
- Robert Fabregat, CEO of Biocat
10:30 h. – Sector challenges and other business insights
- Mariona Serra, Vicepresident of CataloniaBio & HealthTech and Director of GoodGut
- Pedro Luis Sánchez, Director of the Studies Department of Farmaindustria
- Carles Sisternas, Director of Fenin Catalonia
11:00 h. – Strategic facilities serving the BioRegion
Moderated by: Lluís Rovira, CERCA Institution Director (Research Centers of Catalonia)
- Anton Ussi, Operations & Finance Director at EATRIS ERIC
- Josep Maria Martorell, Associate Director of the Barcelona Supercomputing Centre (BSC)
- Mònica Bayès, Strategy Coordinator, National Center for Genomic Analysis (CNAG)
- Caterina Biscari, Director of ALBA Synchrotron
11:30 h. – 12:30h. Coffee – networking
12:30 h. – Fast-tracks for adopting innovation in the Catalan Healthcare System
Moderated by: Ramon Maspons, Chief Health Innovation Strategist, Catalan Ministry of Health
- Fina Lladós, General Director of AMGEN Spain and Portugal
- Chus Castillo, Vice-President Market Access Iberia, ALIRA HEALTH
- Laura Sampietro, President of the Board of Directors of AQuAS and Deputy Director of Innovation, Hospital Clínic Barcelona
- Lluís Juncà, Director General of Innovation, Digital Economy and Entrepreneurship of the Government of Catalonia
13:00 h. – Unlocking access to health data in Europe
Moderated by: Francisco Lupiáñez, Professor of Information and Communication Sciences at UOC
- Montserrat Daban, Director of Science Policy and Internationalization at Biocat
- Jordi Piera, Director of the Digital Health Strategy Office of Catalan Health System
- Sven Parkel, Secretary General of Scan Balt and Board Member at Connected Health, Estonia
- Michel Silvestri, Head of Unit at the Coordination Department of the Swedish eHealth Agency
13:30 h. – Building the future Advanced Therapies Hub of Catalonia
Moderated by: Núria Martí, Director of Innovation and Business Development at Biocat
- Robert Fabregat, CEO of Biocat
- Andreu Mas-Colell, President of the Board of Directors of Blood and Tissue Bank
- Ion Arocena, General Director of AseBio
- Cristina Nadal, Executive Policy Director, MSD - Merck Sharp & Dohme Spain
14:00 h. – Institutional closing
- Hon. Mr. Manel Balcells i Díaz, Minister of Health of the Government of Catalonia
14.10 h. – Lunch - networking
Afternoon session: "European clusters dialogue for transformation"
16:00 – 16.15 h. – Opening keynote: “Helping increase EU's digital resilience”
- Szabolcs Szekacs, Digital Industry Team Leader, European Commission, DG Growth
16:15 – 16.45 h. – Digital transformation: Building capacities
Chair:: Montserrat Daban, Director of Science Policy and Internationalization Biocat
- Björn Arvidsson, Managing Director of STUNS Life Sciences (Sweden)
- Sohail Nourestani, E-Health Consultant of Eurasanté
- Sven Parkel, Secretary General of Scan Balt and Board Member at Connected Health, Estonia
- Szabolcs Szekacs, Digital Industry Team Leader, European Commission, DG Growth
16:45 – 17.15 h. – Building Resilience: From Clusters to Euroclusters
Chair: Javier Selva, CEO, Catalonia Bio & Health Tech
- Karen Lindegaard, International Program Manager of Danish Life Sciences Cluster
- Antonio Novo, President, European Clusters Alliance (Brussels)
- Olga Trofymova, Ukrainian Clusters Alliance
- Marek Przeor, Team Leader, European Commission, Responsible for Cluster Policy
17:15 – 17:45 h. – Sustainable transformation: Biomanufacturing
Chair: Anaïs LeCorvec, Director, Council of European BioRegions
- Tero Piispanen, Senior Executive, HealthTurku, Turku Science Park (Finland)
- Alexandra Patriksson, Science Relations Manager, Testa Center (Sweden)
- Ángeles Barrios, Public Affairs and Stakeholder Relations EIT Health, Spain
17:45 – 18.00 h. – Closing notes: “The Industry of the Future”
- Laura Roman, Industry 5.0 Policy Officer, European Commission
18:00 h. – Closing remarks
- Robert Fabregat, CEO, Biocat
